Yuji Shimura

17PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesLiquid biopsiesCellular immunologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 24, 2026
Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.

|May 10, 2026
Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

|Aug 19, 2024
Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63.

Yui Niiyama-Uchibori, Shinsuke Mizutani, Taku Tsukamoto

|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda

|Sep 05, 2023
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

Yuji Shimura, Hirohiko Shibayama, Aya Nakaya

|Aug 16, 2023
Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma.

Kentaro Mizuhara, Yuji Shimura, Taku Tsukamoto

Pageof 3

Frequent Collaborators

10 joint publications

Junya Kuroda

5 joint publications

Tsutomu Kobayashi

5 joint publications

Takahiro Fujino

2 joint publications

Emiko Sakiyama